Científicos japoneses identifican grupos de proteínas que podrían desencadenar la enfermedad de Alzheimer

21 de julio de 2026

Reportado por IA

Investigadores japoneses han identificado una nueva semilla de la proteína beta-amiloide. El descubrimiento podría conducir a una terapia en etapa temprana para la enfermedad neurodegenerativa.

Según The Japan Times, científicos japoneses han identificado grupos de proteínas que se cree que desencadenan la enfermedad de Alzheimer. El descubrimiento involucra una nueva semilla de la proteína beta-amiloide. Los investigadores afirman que esto podría conducir a una terapia en etapa temprana para la enfermedad neurodegenerativa. El hallazgo fue reportado el 21 de julio de 2026.

Yale study identifies two neuron-surface proteins that help misfolded alpha-synuclein enter brain cells

12 de julio de 2026 Reportado por IA Imagen generada por IA Verificado por hechos

Researchers at Yale School of Medicine say they have identified two proteins on the surface of neurons that help shuttle misfolded alpha-synuclein—a key protein implicated in Parkinson’s disease—into healthy cells, a finding that could point to new strategies aimed at slowing progression.

UC Riverside study proposes new Alzheimer's trigger

Researchers at the University of California, Riverside have proposed that amyloid beta disrupts tau protein function inside neurons, potentially triggering Alzheimer's disease. The findings challenge the focus on external plaques as the primary cause.

Large genetic study uncovers new Alzheimer’s drug targets

1 de junio de 2026 Reportado por IA

A major analysis of genetic data has linked 127 gene locations to Alzheimer’s disease, including 48 previously unidentified ones. Researchers also flagged several genes as promising drug targets and highlighted changes in immune and nerve cells.

Health

Study finds blood-cancer-linked mutations in brain immune cells tied to Alzheimer’s pathology

Health

New cell death process linked to Alzheimer's disease

Health

Cochrane review questions benefits of anti-amyloid Alzheimer’s drugs

Speed training game alters amyloid levels in men's brains

A cognitive speed-training game that reduces dementia risk appears to boost the brain's clearance of a key protein in men but not women, according to new research presented this week.

SORLA protein found to shield brain from Alzheimer’s tau damage

20 de julio de 2026 Reportado por IA

A protein known as SORLA can reduce the toxic effects of tau tangles linked to Alzheimer’s disease. Researchers at Sanford Burnham Prebys showed that higher levels of the protein limited brain atrophy and preserved neuron connections in mice. The findings were published July 17 in Science Advances.

20 de junio de 2026 04:12

Científicos japoneses identifican grupos de proteínas que podrían desencadenar la enfermedad de Alzheimer

Artículos relacionados

Yale study identifies two neuron-surface proteins that help misfolded alpha-synuclein enter brain cells

UC Riverside study proposes new Alzheimer's trigger

Large genetic study uncovers new Alzheimer’s drug targets

Study finds blood-cancer-linked mutations in brain immune cells tied to Alzheimer’s pathology

New cell death process linked to Alzheimer's disease

Cochrane review questions benefits of anti-amyloid Alzheimer’s drugs

Speed training game alters amyloid levels in men's brains

SORLA protein found to shield brain from Alzheimer’s tau damage

Blood test can reveal Alzheimer's signs years ahead

USC researchers identify compounds targeting Alzheimer’s brain inflammation

Indiana university team targets idol enzyme to treat alzheimer's

Nanoparticles reduced amyloid-β and improved cognition in an Alzheimer’s mouse model, researchers report

Scientists restore memory in Alzheimer's mice by blocking PTP1B

Este sitio web utiliza cookies